FDA Investigator Sereen Gmorgan Murray

Sereen Gmorgan Murray has conducted inspections on 71 sites in 4 countries as of 18 Oct 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:

Last Inspection Date:

18 Oct 2021

Investigator Role:

FDA Investigator

Redica ID:

100008149

Countries of Inspections:

United States of America, Hungary, Korea (Republic of), New Zealand

FDA Investigators that have inspected at least one site in common with Sereen Gmorgan Murray:

Alan R Moore, Ann B Borromeo, Anne E Johnson, Anthony S Puckett, April R Bowen, Arlyss M Jones, Barbara M Frazier, Betsy C Galliher, Bonita S Chester, Brandy D Brown, Cheryl A Grandinetti, Christopher M Jeffers, Claudele S Razo, Craig A Garmendia, Cynthia F Kleppinger, MD, David T Glover, Dawn C Olenjack, Derek C Price, Devaughn Edwards, Dr. Koffi A Amegadje, Edward Deberry, Eileen J Bannerman, Ernest H Blackwood, Ingrid A Zambrana, Jackie M Douglas, Jawaid Hamid, John D Lloyd, Joseph F Owens, Karen M Cooper, Kassa Ayalew, MD, Kent A Conforti, Lareese K Thomas, Laura L Staples, Lawrence Thomas, Leah M Andrews, Leon L Crawley, Marshall A Naimo, Matthew R Coleman, Michelle D Haamid, Michelle M Noe Varga, Myla D Chapman, N'jere English, Nicole M Bell, Patricia S Smith, Sandra I Gaul, Sheri S Oliver, Stephanie E Hubbard, Tracy R Ball, Tyrico K English, Vanessa E Coulter, Viviana Matta, William P Tonkins

Sereen Gmorgan Murray's Documents

Publish Date	Document Type	Title
April, 2016	FDA 483	J. David Lentz III, M.D. - Form 483, 2016-04-25
October, 2019	FDA 483	Kennedy, Philip R. - Form 483, 2019-10-16
August, 2016	EIR	Martin Throne MD - EIR, 2016-08-05
March, 2016	EIR	Phoebe Putney Mem Hosp Irc - EIR, 2016-03-03
November, 2017	FDA 483	O'Barr, Thomas MD - Form 483, 2017-11-30
October, 2018	FDA 483	Naomi Akita, MD - Form 483, 2018-10-11
October, 2016	EIR	Sagar Lonial, M.D. - EIR, 2016-10-28
November, 2021	FDA 483	Daniel C. Tarquinio, DO - Form 483, 2021-11-05
May, 2021	EIR	PPD, Inc., part of Thermo Fisher Scientific - EIR, 2021-05-21
September, 2019	FDA 483	Laura Mulloy, D.O. - Form 483, 2019-09-11
February, 2018	FDA 483	Wellstar Atlanta Medical Center IRB#1 - Form 483, 2018-02-15
March, 2017	FDA 483	Robert Donald Harvey - Form 483, 2017-03-24
April, 2018	FDA 483	Theresa Lawrence Ford - Form 483, 2018-04-03
March, 2018	FDA 483	Georgia STE DEPT Human Resources IRB#1 - Form 483, 2018-03-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

Total inspections conducted
483 rate
OAI rate
Warning Letter rate
Inspections by Industry, Scope, and Inspection Reason
And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

Talk to sales to access our investigator profiles

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

Pre-Approval Inspection (PAI) trends
The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
Latest 483s: see what the trends are across all FDA Investigators
CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

Full inspection histories for your vendors down to the specific site level
All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more